Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Federal Trade Commission
Daiichi Sankyo

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020067

« Back to Dashboard

NDA 020067 describes EC-NAPROSYN, which is a drug marketed by Atnahs Pharma Us and is included in one NDA. It is available from three suppliers. Additional details are available on the EC-NAPROSYN profile page.

The generic ingredient in EC-NAPROSYN is naproxen. There are forty-two drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the naproxen profile page.

Summary for 020067

Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020067

Medical Subject Heading (MeSH) Categories for 020067

Suppliers and Packaging for NDA: 020067

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EC-NAPROSYN naproxen TABLET, DELAYED RELEASE;ORAL 020067 NDA Genentech, Inc. 0004-6415 0004-6415-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0004-6415-01)
EC-NAPROSYN naproxen TABLET, DELAYED RELEASE;ORAL 020067 NDA Genentech, Inc. 0004-6416 0004-6416-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0004-6416-01)

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET, DELAYED RELEASE;ORALStrength375MG
Approval Date:Oct 14, 1994TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET, DELAYED RELEASE;ORALStrength500MG
Approval Date:Oct 14, 1994TE:ABRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Daiichi Sankyo
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: